
Oregon Bio Weekly Newsletter- –> 4-7-2021
Read all about it! Check out all the stories in this week’s newsletter – click here. Learn more about: How to apply for BIO’s Startup Stadium Advocacy Alert: Stop House
Read all about it! Check out all the stories in this week’s newsletter – click here. Learn more about: How to apply for BIO’s Startup Stadium Advocacy Alert: Stop House
2020 was a year like no other in biotech and the life sciences, and the need for a pivot-worthy workforce has never been more needed. While physicians and care
By Elizabeth Hayes – Staff Reporter, Portland Business Journal, 2/9/2021 Genentech’s $175 million expansion in Hillsboro is almost complete. The biotech giant is getting ready to open a 130,000-square-foot expansion in
FOR IMMEDIATE RELEASE – – February 8, 2021 (Portland, Ore.) – Dan Snyder, MBA, local medical diagnostics corporate executive, will lead 2021 Oregon Bioscience Association (Oregon Bio)’s board of directors.
Winning researchers and startup entrepreneurs capture prizes in four categories at Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics conference (Portland, Ore.) – Winners are now being
Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics happens over three half-days Nov. 17, 18, 19 and brings together investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain
Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech By Taylor Soper – https://www.geekwire.com/2020/synthetic-biology-startup-absci-raises-65m-expand-protein-printing-tech/ Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology
By Corina Stef – https://www.cpexecutive.com/post/top-5-office-projects-under-construction-in-portland/ Top 5 Office Projects Under Construction in Portland Based on Yardi Matrix data, 2.5 million square feet of office space was underway as of October, including
By Dave Sebastian – https://www.marketscreener.com/quote/stock/THERMO-FISHER-SCIENTIFIC-14623/news/Thermo-Fisher-Scientific-Expects-2020-Revenue-to-Grow-20-31583605/ Thermo Fisher Scientific Inc. executives said the company expects 2020 revenue to grow 20% to about $30.52 billion, its first full-year outlook since it withdrew
— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States — — Veklury Shortened Time to Recovery By Five Days in Hospitalized COVID-19 Patients — Gilead
Credit: https://www.cnbc.com/2020/10/09/covid-19-drives-historic-demand-for-life-sciences-real-estate-.html All the fundamentals are aligning for the life sciences industry, as Covid-19 accelerates already growing demand for real estate in the sector. Rents are rising for lab space,
Oregon Bioscience Association Copyright 2023. All Rights Reserved.